Form 4 holding
Chief Medical Officer
Viridian Therapeutics, Inc.\DE
- Security class
- Common Stock
- Shares / value
- 40,000
- Estimated value
- $734,800
- Report date
- 14 Aug 2026
- Price
- $18.37
- Ownership
- Direct
Radhika Tripuraneni - Chief Medical Officer at Viridian Therapeutics, Inc.\DE
Issuer-level insider activity
- Role
- Chief Medical Officer
- Issuer ticker
- VRDN on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Radhika Tripuraneni since 28 Aug 2025
Reported holdings for Radhika Tripuraneni in Viridian Therapeutics, Inc.\DE
Form 4 holding
Chief Medical Officer
Viridian Therapeutics, Inc.\DE
- Security class
- Restricted Stock Units
- Shares / value
- 19,150
- Estimated value
- Report date
- 02 Mar 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Chief Medical Officer
Viridian Therapeutics, Inc.\DE
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 0
- Estimated value
- Report date
- 14 Aug 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Radhika Tripuraneni in Viridian Therapeutics, Inc.\DE
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.